PortalPublikationenTypisches Vorhofflattern: Diagnostik und Therapie

Typisches Vorhofflattern: Diagnostik und Therapie

Standard

Typisches Vorhofflattern: Diagnostik und Therapie. / Thomas, Dierk; Eckardt, Lars; Estner, Heidi L; Kuniss, Malte; Meyer, Christian; Neuberger, Hans-Ruprecht; Sommer, Philipp; Steven, Daniel; Voss, Frederik; Bonnemeier, Hendrik.

in: Herzschrittmacherther Elektrophysiol, Jahrgang 27, Nr. 1, 03.2016, S. 46-56.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Review › Forschung

Harvard

Thomas, D, Eckardt, L, Estner, HL, Kuniss, M, Meyer, C, Neuberger, H-R, Sommer, P, Steven, D, Voss, F & Bonnemeier, H 2016, 'Typisches Vorhofflattern: Diagnostik und Therapie', Herzschrittmacherther Elektrophysiol, Jg. 27, Nr. 1, S. 46-56. https://doi.org/10.1007/s00399-016-0413-y

APA

Thomas, D., Eckardt, L., Estner, H. L., Kuniss, M., Meyer, C., Neuberger, H-R., Sommer, P., Steven, D., Voss, F., & Bonnemeier, H. (2016). Typisches Vorhofflattern: Diagnostik und Therapie. Herzschrittmacherther Elektrophysiol, 27(1), 46-56. https://doi.org/10.1007/s00399-016-0413-y

Vancouver

Thomas D, Eckardt L, Estner HL, Kuniss M, Meyer C, Neuberger H-R et al. Typisches Vorhofflattern: Diagnostik und Therapie. Herzschrittmacherther Elektrophysiol. 2016 Mär;27(1):46-56. https://doi.org/10.1007/s00399-016-0413-y

Bibtex

@article{d014c8baf2ba45fba87bc279662a88fc,
title = "Typisches Vorhofflattern: Diagnostik und Therapie",
abstract = "Typical, cavotricuspid-dependent atrial flutter is the most common atrial macroreentry tachycardia. The incidence of atrial flutter (typical and atypical forms) is age-dependent with 5/100,000 in patients less than 50 years and approximately 600/100,000 in subjects > 80 years of age. Concomitant heart failure or pulmonary disease further increases the risk of typical atrial flutter.Patients with atrial flutter may present with symptoms of palpitations, reduced exercise capacity, chest pain, or dyspnea. The risk of thromboembolism is probably similar to atrial fibrillation; therefore, the same antithrombotic prophylaxis is required in atrial flutter patients. Acutely symptomatic cases may be subjected to cardioversion or pharmacologic rate control to relieve symptoms. Catheter ablation of the cavotricuspid isthmus represents the primary choice in long-term therapy, associated with high procedural success (> 97 %) and low complication rates (0.5 %).This article represents the third part of a manuscript series designed to improve professional education in the field of cardiac electrophysiology. Mechanistic and clinical characteristics as well as management of isthmus-dependent atrial flutter are described in detail. Electrophysiological findings and catheter ablation of the arrhythmia are highlighted.",
keywords = "Atrial Flutter/complications, Body Surface Potential Mapping/methods, Catheter Ablation/methods, Combined Modality Therapy/methods, Diagnosis, Differential, Electrocardiography/methods, Evidence-Based Medicine, Fibrinolytic Agents/administration & dosage, Thromboembolism/etiology, Treatment Outcome",
author = "Dierk Thomas and Lars Eckardt and Estner, {Heidi L} and Malte Kuniss and Christian Meyer and Hans-Ruprecht Neuberger and Philipp Sommer and Daniel Steven and Frederik Voss and Hendrik Bonnemeier",
year = "2016",
month = mar,
doi = "10.1007/s00399-016-0413-y",
language = "Deutsch",
volume = "27",
pages = "46--56",
journal = "Herzschrittmacherther Elektrophysiol",
issn = "1435-1544",
publisher = "D. Steinkopff-Verlag",
number = "1",

}

RIS

TY - JOUR

T1 - Typisches Vorhofflattern: Diagnostik und Therapie

AU - Thomas, Dierk

AU - Eckardt, Lars

AU - Estner, Heidi L

AU - Kuniss, Malte

AU - Meyer, Christian

AU - Neuberger, Hans-Ruprecht

AU - Sommer, Philipp

AU - Steven, Daniel

AU - Voss, Frederik

AU - Bonnemeier, Hendrik

PY - 2016/3

Y1 - 2016/3

N2 - Typical, cavotricuspid-dependent atrial flutter is the most common atrial macroreentry tachycardia. The incidence of atrial flutter (typical and atypical forms) is age-dependent with 5/100,000 in patients less than 50 years and approximately 600/100,000 in subjects > 80 years of age. Concomitant heart failure or pulmonary disease further increases the risk of typical atrial flutter.Patients with atrial flutter may present with symptoms of palpitations, reduced exercise capacity, chest pain, or dyspnea. The risk of thromboembolism is probably similar to atrial fibrillation; therefore, the same antithrombotic prophylaxis is required in atrial flutter patients. Acutely symptomatic cases may be subjected to cardioversion or pharmacologic rate control to relieve symptoms. Catheter ablation of the cavotricuspid isthmus represents the primary choice in long-term therapy, associated with high procedural success (> 97 %) and low complication rates (0.5 %).This article represents the third part of a manuscript series designed to improve professional education in the field of cardiac electrophysiology. Mechanistic and clinical characteristics as well as management of isthmus-dependent atrial flutter are described in detail. Electrophysiological findings and catheter ablation of the arrhythmia are highlighted.

AB - Typical, cavotricuspid-dependent atrial flutter is the most common atrial macroreentry tachycardia. The incidence of atrial flutter (typical and atypical forms) is age-dependent with 5/100,000 in patients less than 50 years and approximately 600/100,000 in subjects > 80 years of age. Concomitant heart failure or pulmonary disease further increases the risk of typical atrial flutter.Patients with atrial flutter may present with symptoms of palpitations, reduced exercise capacity, chest pain, or dyspnea. The risk of thromboembolism is probably similar to atrial fibrillation; therefore, the same antithrombotic prophylaxis is required in atrial flutter patients. Acutely symptomatic cases may be subjected to cardioversion or pharmacologic rate control to relieve symptoms. Catheter ablation of the cavotricuspid isthmus represents the primary choice in long-term therapy, associated with high procedural success (> 97 %) and low complication rates (0.5 %).This article represents the third part of a manuscript series designed to improve professional education in the field of cardiac electrophysiology. Mechanistic and clinical characteristics as well as management of isthmus-dependent atrial flutter are described in detail. Electrophysiological findings and catheter ablation of the arrhythmia are highlighted.

KW - Atrial Flutter/complications

KW - Body Surface Potential Mapping/methods

KW - Catheter Ablation/methods

KW - Combined Modality Therapy/methods

KW - Diagnosis, Differential

KW - Electrocardiography/methods

KW - Evidence-Based Medicine

KW - Fibrinolytic Agents/administration & dosage

KW - Thromboembolism/etiology

KW - Treatment Outcome

U2 - 10.1007/s00399-016-0413-y

DO - 10.1007/s00399-016-0413-y

M3 - SCORING: Review

C2 - 26846223

VL - 27

SP - 46

EP - 56

JO - Herzschrittmacherther Elektrophysiol

JF - Herzschrittmacherther Elektrophysiol

SN - 1435-1544

IS - 1

ER -